Autograft beats mitomycin C for pterygium recurrence; 0.04% atropine slows myopia most; retinal occlusion patients get less brain imaging

Listen to this post
read by AI voices · all episodesConjunctival autograft produced the lowest 12-month recurrence after pterygium surgery, 5.0%, versus 13.7% with mitomycin C and 22.9% with amniotic membrane, in a 750-patient randomized trial in JAMA Ophthalmology.
In children with myopia and intermittent exotropia, 0.04% atropine slowed progression more than lower doses. Patients with retinal artery occlusion got brain imaging less often than matched patients with transient ischemic attack.
- Research Nov 19, 2026In a multicenter, open-label randomized trial with masked outcome assessment at five tertiary hospitals in China, published in JAMA Ophthalmology, 750 patients with primary pterygium were assigned to amniotic membrane transplant, intraoperative mitomycin C or conjunctival autograft. Intention-to-treat recurrence at 12 months was 22.9%, 13.7% and 5.0%, respectively. The risk difference was 8.7 percentage points for mitomycin C versus autograft (98.33% CI 2.2 to 15.2, P = .001) and 17.9 for amniotic membrane versus autograft (98.33% CI 10.5 to 25.4, P < .001).Sources: JAMA Ophthalmology, PubMed
- Research Nov 19, 2026In the single-center, double-masked AMIXT2 trial in JAMA Ophthalmology, 264 children with myopia and intermittent exotropia were randomized to 0.01%, 0.02% or 0.04% atropine drops; 224 (84.8%) completed 12 months. Mean 12-month change in cycloplegic spherical equivalent was -0.43, -0.35 and -0.18 diopters, respectively, and the difference for 0.04% versus 0.01% was 0.24 diopters (95% CI 0.11 to 0.37, P < .001). The authors said 0.04% was associated with less myopia progression and axial elongation over 12 months.Sources: JAMA Ophthalmology, PubMed
- Research Nov 16, 2026A study in Ophthalmology compared 3,695 matched pairs of patients with same-date emergency department contacts for retinal artery occlusion or transient ischemic attack (TIA). Retinal artery occlusion was associated with lower use of brain imaging, 77.3% versus 91.7%, and slightly higher use of cervical imaging, 81.7% versus 79.2%.Sources: Ophthalmology, PubMed
The weekly innovation roundup for ophthalmology, published every Sunday for the week before; every item links to its sources. Latest ophthalmology news · All specialties